Trading News
Sep. 8, 20233 min read

$BIOC: Did You Avoid This Failing Stock?

Tim BohenAvatar
Written by Tim Bohen

If you’re like most traders, you were probably excited to see a low-float healthcare stock with news running in premarket on Friday… 

Especially since those are some of the biggest runners we’ve seen lately like Palisade Bio, Inc. (NASDAQ: PALI) and NeuBase Therapeutics, Inc. (NASDAQ: NBSE)

You might’ve even been rubbing your hands together in eager anticipation of a Friday squeeze and some big gains for your account… 

But while Biocept, Inc. (NASDAQ: BIOC) did have some of the criteria we looked for lately — it didn’t have the same result as some of the other recent runners. 

You might’ve been caught in a losing trade and finished off the trading week feeling deflated and disappointed. 

But I can help you avoid that this week… 

Because there was one thing BIOC had in common with the other big runners that could’ve prevented you from entering a losing trade…

How To Avoid Losing Trades

In Friday’s Daily Accelerator, I went into detail about what four of the latest biggest runners had in common… 

And how it could’ve helped you plan entries in those stocks for up to 148% gains. 

BIOC had the same thing in common. 

But instead of leading you to a huge winning trade, it could’ve saved you from a losing one. 

Just like Verb Technology Company, Inc. (NASDAQ: VERB), Palisade Bio, Inc. (NASDAQ: PALI), NeuBase Therapeutics, Inc. (NASDAQ: NBSE), and American Rebel Holdings, Inc. (NASDAQ: AREB) before their big runs…

Biocept, Inc. (NASDAQ: BIOC) was on Oracle on Friday morning. 

So our stock-picking algorithm identified it as a stock with the potential to explode….

After all, it had the criteria we look for: 

  • Low float stock. 
  • With news.
  • Gapping up in premarket. 
  • Trading high volume. 
  • Hot sector.

But instead of getting emotional and excited about a trade like humans tend to do… 

Which can lead to anticipation and an early entry resulting in a loss…

Oracle just shows you a level to use as an entry. 

If it hits the level, there’s a potential trade. If the stock doesn’t hit the signal entry, you don’t take a trade and ignore the stock. 

It’s that simple. 

It can help you cut out emotional mistakes and can save you from getting caught in stocks that fail at the open like BIOC. 

BIOC chart: 1-day, 5-minute candle — courtesy of

The stock never hit Oracle’s $1.86 entry price, so there was no trade and no loss. 

Just another good reason to use tech tools to your advantage. 

Learn how you can spot the good trades and avoid the bad — attend one of our free live training sessions

We go over the day’s top trades, watchlist building, and trading plans all live. Sign up here now

Have a great day everyone. See you back here tomorrow. 

Tim Bohen

Lead Trainer, StocksToTrade